Main
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
Register:
|
ClinicalTrials.gov |
Last refreshed on:
|
12 December 2020 |
Main ID: |
NCT03403985 |
Date of registration:
|
05/01/2018 |
Prospective Registration:
|
No |
Primary sponsor: |
|
Public title:
|
Long-term Evaluation of Direct Pulp Capping
|
Scientific title:
|
Long-term Evaluation of Direct Pulp Capping Using Either Mineral Trioxid Aggregate or Calcium Hydroxide in Permanent Mature Teeth: A Randomized Controlled Trial |
Date of first enrolment:
|
June 1, 2017 |
Target sample size:
|
80 |
Recruitment status: |
Active, not recruiting |
URL:
|
https://clinicaltrials.gov/show/NCT03403985 |
Study type:
|
Interventional |
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Single (Participant).
|
Phase:
|
N/A
|
|
Countries of recruitment
|
Jordan
| | | | | | | |
Contacts
|
Name:
|
Lama Awawdeh, PhD |
Address:
|
|
Telephone:
|
|
Email:
|
|
Affiliation:
|
Jordan University of Science and Technology |
| | |
Key inclusion & exclusion criteria
|
Inclusion Criteria:
1. carious teeth that had no previous root canal treatment
2. Pulpal diagnosis of normal or reversible pulpitis
Exclusion Criteria:
1. History of irreversible pulpal pain
2. Immature teeth
3. Non restorable teeth
4. Teeth with active periodontal disease
5. History of any systemic disease
6. Concurrent medication with systemic steroids, antibiotics, analgesics,
immunomodulatory drugs or cytotoxics
Age minimum:
12 Years
Age maximum:
N/A
Gender:
All
|
Health Condition(s) or Problem(s) studied
|
Dental Pulp Capping
|
Dental Caries Extending to Pulp
|
Intervention(s)
|
Drug: Calcium Hydroxide (Ca(OH)2)
|
Drug: Mineral Trioxide Aggregate
|
Primary Outcome(s)
|
clinical vital pulp therapy success
[Time Frame: from date of randomization until failure reported for up to 100 months]
|
Secondary Outcome(s)
|
Radiographic success
[Time Frame: from date of randomization until failure reported for up to 100 months]
|
Secondary ID(s)
|
JordanUST2
|
Source(s) of Monetary Support
|
Please refer to primary and secondary sponsors
|
Results
|
Results available:
|
|
Date Posted:
|
|
Date Completed:
|
|
URL:
|
|
|
|